VJOncology is committed to improving our service to you

ECCO 2017 | Managing toxicity from immunotherapy

VJOncology is committed to improving our service to you

Martin Gore

Martin Gore, PhD, FRCP, CBE from the Royal Marsden NHS Foundation, London, UK discusses the risks from immunotherapy at the European Cancer Congress of the European Cancer Organisation (ECCO) 2017 in Amsterdam, Netherlands. Toxicity from immunotherapy is a significant consideration as they can lead to complex consequences, in particular, the combination of immune checkpoint inhibitors and CAR T-cells. Toxicity management is therefore something that needs to become more organised and managed.

Share this video  
27th January 2017

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter